LA
IMGN

Lee Ainslie’s Immunogen Inc IMGN Stock Holding History

Lee Ainslie’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,493,217
Closed -$73.9M – 572
2023
Q4 		$73.9M Sell
2,493,217
-25,310
-1% -$504K 1.48% 21
2023
Q3 		$40M Sell
2,518,527
-1,268,371
-33% -$21.1M 0.9% 27
2023
Q2 		$71.5M Sell
3,786,898
-4,069,511
-52% -$48M 1.52% 18
2023
Q1 		$30.2M Buy
7,856,409
+977,466
+14% +$4.17M 0.76% 29
2022
Q4 		$34.1M Buy
6,878,943
+3,325,815
+94% +$18M 0.81% 31
2022
Q3 		$17M Buy
3,553,128
+786,654
+28% +$4.15M 0.38% 43
2022
Q2 		$12.4M Buy
+2,766,474
New +$12M 0.31% 48

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Lee Ainslie's IMGN Position: Q1 2024 in Review

Lee Ainslie sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,493,217 shares — an estimated $73.9M sold.

Lee Ainslie first reported a position in IMGN in Q2 2022 and held it in 7 quarters. The position peaked at $73.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Lee Ainslie reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Lee Ainslie sold 2,493,217 Immunogen Inc shares in Q1 2024, an estimated $73.9M.
  • Lee Ainslie first reported a position in Immunogen Inc in Q2 2022 and held it in 7 quarters.
  • Lee Ainslie's Immunogen Inc position peaked at $73.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.